MedPath

Found 556472 clinical trials

Sort by:

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

Not Applicable

Not yet recruiting

Conditions: Advanced or Metastatic Solid Tumors

Interventions: Drug: TAK-188

First Posted Date: 2025-10-03

Last Posted Date: 2025-10-03

Lead Sponsor: Takeda

Target Recruit Count: 223

Registration Number: NCT07205718

Locations: 🇺🇸
UCLA Health-Santa Monica Cancer Care (Cancer Care - Santa Monica), Santa Monica, California, United States
🇺🇸
Yale School of Medicine - Smilow Cancer Hospital - Center for Thoracic Cancers, New Haven, Connecticut, United States
🇺🇸
Florida Cancer Specialists - Lake Nona, Orlando, Florida, United States

and more 12 locations

Cardiovascular Disease CVD Constitutes a Significant Health Challenge for Individuals With Type 2 Diabetes Mellitus T2DM, Affecting Approximately 32% of This Population and Contributing Significantly to Global Mortality.Visceral Adipose Tissue VAT Accumulation Has Been Recognize

Not yet recruiting

Conditions: Diabete Mellitus

First Posted Date: 2025-10-02

Last Posted Date: 2025-10-02

Lead Sponsor: Assiut University

Target Recruit Count: 238

Registration Number: NCT07204782

Locations: 🇪🇬
Assiut university, Asyut, Egypt

Towards Efficient Personalization of Computerized Lower Limb Prostheses Via Reinforcement Learning in a Clinical Setup - Group 1

Not Applicable

Recruiting

Conditions: Transfemoral Amputation

First Posted Date: 2025-10-02

Last Posted Date: 2025-10-02

Lead Sponsor: North Carolina State University

Target Recruit Count: 24

Registration Number: NCT07204925

Locations: 🇺🇸
North Carolina State University, Raleigh, North Carolina, United States

Effect of Tongue-to-Palate Resistance Training in Geriatric Patients With Oropharyngeal Dysphagia

Not Applicable

Completed

Conditions: Oropharyngeal Dysphagia
Geriatric Patients

First Posted Date: 2025-10-02

Last Posted Date: 2025-10-02

Lead Sponsor: Dr Cipto Mangunkusumo General Hospital

Target Recruit Count: 17

Registration Number: NCT07203508

Locations: 🇮🇩
RSUPN Dr. Cipto Mangunkusumo, Jakarta Pusat, Jakarta Special Capital Region, Indonesia

The IVO-LUNG Study

Not Applicable

Not yet recruiting

Conditions: Non Small Cell Lung Cancer (Stage III)

Interventions: Drug: Ivonescimab

First Posted Date: 2025-10-02

Last Posted Date: 2025-10-02

Lead Sponsor: Sun Yat-sen University

Target Recruit Count: 63

Registration Number: NCT07204548

Locations: 🇨🇳
Li-Kun Chen, Guangzhou, Guangzhou, China

Biopsychosocial Factors and Muscle Morphology After a Resistance Exercise

Not Applicable

Not yet recruiting

Conditions: Low Back Pain, Chronic

First Posted Date: 2025-10-02

Last Posted Date: 2025-10-02

Lead Sponsor: University of Central Florida

Target Recruit Count: 22

Registration Number: NCT07203430

Locations: 🇺🇸
University of Central Florida, Orlando, Florida, United States

Comparison of Effectiveness of Low Dose Laser and Transcutaneous Electrical Stimulation in Hemiplegic Shoulder

Not Applicable

Recruiting

Conditions: Hemiplegic Shoulder Pain

First Posted Date: 2025-10-02

Last Posted Date: 2025-10-02

Lead Sponsor: Ankara Etlik City Hospital

Target Recruit Count: 45

Registration Number: NCT07203222

Locations: Ankara Etlik City Hospital, Ankara, Yenimahalle, Turkey (Türkiye)

Evaluation of a Medical Device Based on Isotonic Seawater and Hyaluronic Acid Used as a Nasal Spray

Not Applicable

Not yet recruiting

Conditions: Nasal Dryness

First Posted Date: 2025-10-02

Last Posted Date: 2025-10-08

Lead Sponsor: YSLab

Target Recruit Count: 65

Registration Number: NCT07204158

Phase 4 Study of Laybon Tab. in Knee Osteoarthritis

Not Applicable

Not yet recruiting

Conditions: Osteoarthritis, Knee
Osteoarthritis

Interventions: Drug: Laybon Tab.
Drug: Layla Tab.

First Posted Date: 2025-10-02

Last Posted Date: 2025-10-02

Lead Sponsor: Mather's Pharm. Co., Ltd.

Target Recruit Count: 172

Registration Number: NCT07203547

Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.

Not Applicable

Not yet recruiting

Conditions: Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant Recipients

First Posted Date: 2025-10-02

Last Posted Date: 2025-10-02

Lead Sponsor: Hospital Universitario La Paz

Target Recruit Count: 30

Registration Number: NCT07203664

Locations: 🇪🇸
Hospital Universitario La Paz, Pº de la Castellana, 261 (Servicio de Nefrologia), Madrid, Madrid, Spain

AI-Powered Research

Premium Access

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

Cardiovascular Disease CVD Constitutes a Significant Health Challenge for Individuals With Type 2 Diabetes Mellitus T2DM, Affecting Approximately 32% of This Population and Contributing Significantly to Global Mortality.Visceral Adipose Tissue VAT Accumulation Has Been Recognize

Towards Efficient Personalization of Computerized Lower Limb Prostheses Via Reinforcement Learning in a Clinical Setup - Group 1

Effect of Tongue-to-Palate Resistance Training in Geriatric Patients With Oropharyngeal Dysphagia

The IVO-LUNG Study

Biopsychosocial Factors and Muscle Morphology After a Resistance Exercise

Comparison of Effectiveness of Low Dose Laser and Transcutaneous Electrical Stimulation in Hemiplegic Shoulder

Evaluation of a Medical Device Based on Isotonic Seawater and Hyaluronic Acid Used as a Nasal Spray

Phase 4 Study of Laybon Tab. in Knee Osteoarthritis

Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.

Product

Company

Legal